Grail Inc (GRAL)
27.70 x 10 30.27 x 2
Pre-market by (Cboe BZX)
28.58 +0.19 (+0.67%) 03/27/25 [NASDAQ]
27.70 x 10 30.27 x 2
Pre-market 27.71 -0.87 (-3.04%) 08:55 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | GRAL | GERN | NRIX | ||
Company | Grail Inc | Geron Corp | Nurix Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 29.00 | 1.6500 | 12.84 | ||
High | 29.00 | 1.6500 | 13.10 | ||
Low | 29.00 | 1.6500 | 12.39 | ||
Last | 29.00 | 1.6500 | 12.55 | ||
Change | +0.42 | unch | -0.18 | ||
% Change | +1.47% | unch | -1.41% | ||
Volume | 1,093 | 13,756 | 577,800 | ||
20-Day Average Volume | 1,362,805 | 14,136,038 | 946,825 | ||
Previous Close | 28.58 | 1.6500 | 12.73 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 31.27 | 1.6990 | 13.72 | ||
20-Day Raw Stochastic | 13.10% | 23.53% | 10.57% | ||
20-Day Relative Strength | 46.45% | 33.10% | 33.81% | ||
Weighted Alpha | -2.83 | -58.78 | -42.76 | ||
Today's Opinion | N/A | 100% Sell | 100% Sell | ||
Previous Opinion | N/A | 100% Sell | 100% Sell | ||
Last Month's Opinion | N/A | 100% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -4.26% since 03/21/25 | -9.34% since 03/21/25 | -9.52% since 03/20/25 | ||
Low | 26.75 on 03/27/25 | 1.6300 on 03/26/25 | 12.20 on 03/26/25 | ||
High | 33.49 on 03/24/25 | 1.8299 on 03/24/25 | 13.67 on 03/21/25 | ||
1-Month | |||||
%Chg | -24.79% since 02/28/25 | -6.25% since 02/28/25 | -16.33% since 02/27/25 | ||
Low | 26.51 on 03/14/25 | 1.5700 on 03/11/25 | 12.20 on 03/26/25 | ||
High | 45.51 on 03/04/25 | 1.9100 on 03/03/25 | 15.51 on 03/03/25 | ||
3-Month | |||||
%Chg | +47.96% since 12/27/24 | -50.75% since 12/27/24 | -34.33% since 12/27/24 | ||
Low | 16.56 on 01/16/25 | 1.4601 on 02/26/25 | 12.20 on 03/26/25 | ||
High | 63.99 on 02/18/25 | 3.6800 on 01/03/25 | 20.66 on 01/27/25 | ||
6-Month | |||||
%Chg | +101.39% since 09/27/24 | -63.89% since 09/27/24 | -45.55% since 09/27/24 | ||
Low | 12.33 on 10/07/24 | 1.4601 on 02/26/25 | 12.20 on 03/26/25 | ||
High | 63.99 on 02/18/25 | 4.6500 on 09/30/24 | 29.56 on 11/11/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 968,719 | 1,050,892 | 952,382 | ||
Shares Outstanding, K | 33,895 | 636,904 | 75,887 | ||
Annual Sales | 125,600,000 | 76,990,000 | 54,550,000 | ||
Annual Net Income | -2,027,010,000 | -174,570,000 | -193,570,000 | ||
Last Quarter Sales | 38,250,000 | 47,540,000 | 13,280,000 | ||
Last Quarter Net Income | -97,070,000 | -25,350,000 | -58,550,000 | ||
60-Month Beta | N/A | 0.53 | 2.18 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.86 on 02/20/25 | -0.04 on 02/26/25 | -0.75 on 01/28/25 | ||
Latest Earnings Date | 05/15/25 | 05/01/25 | 04/09/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |